VENABLE LLP

Lobbying for DRUGS FOR NEGLECTED DISEASES INITIATIVE NORTH AMERICA · Non-profit product development partnership

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · New York · $10,000.00 income · posted Oct 14, 2025

Lobbying activity 1

Budget/Appropriations

FY 2026 Labor, Health and Human Services, Education and State and Foreign Operations funding for global health research and development and neglected tropical diseases FY 2026 global health research and development funding Issues related to global health

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.